Adjuvant tamoxifen in postmenopausal women with high-risk breast cancer
Phase of Trial: Phase III
Latest Information Update: 14 Dec 2013
At a glance
- Drugs Tamoxifen (Primary)
- Indications Early breast cancer; Menopause
- Focus Biomarker; Therapeutic Use
- 14 Dec 2013 Results presented at the 36th Annual San Antonio Breast Cancer Symposium.
- 13 Dec 2013 Primary endpoint 'Disease-free-survival' has been met.
- 13 Dec 2013 Primary endpoint 'Death-rate' has been met.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History